Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis C

Free Subscription 31.10.2022 1 Clin Res Hepatol Gastroenterol 3 J Viral Hepat 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Clin Res Hepatol Gastroenterol

1. EL-KASSAS M, Elbehiry S, Rezk E, Omran D, et al
   Discontinuing Directly Acting Antivirals During Hepatitis C Treatment: Highlighting an Infrequent but Hostile Event.
   Clin Res Hepatol Gastroenterol. 2022 Oct 22:102042.
   PubMed        
   
   

   
   J Viral Hepat

2. BITTENCOURT PL, Iasi MDSF, Viana MV, Crespo DM, et al
   Poor linkage to care may compromise the brazilian plan for hepatitis c elimination.
   J Viral Hepat. 2022 Oct 27. doi: 10.1111/jvh.13762.
   PubMed         Abstract available
   
   
3. CASEY JL, Dore GJ, Grebely J, Matthews GV, et al
   Hepatitis C Virus-Specific Immune Responses Following Direct Acting Antivirals Administered During Recent Hepatitis C Virus Infection.
   J Viral Hepat. 2022 Oct 27. doi: 10.1111/jvh.13761.
   PubMed         Abstract available
   
   
4. CHADHA N, Turner A, Sterling RK
   Prevalence and predictors of abnormal alanine aminotransferase in patients with HCV who have achieved SVR.
   J Viral Hepat. 2022 Oct 27. doi: 10.1111/jvh.13763.
   PubMed         Abstract available
   
   

   
   PLoS One

5. YAMATAKA K, Chu PS, Koda Y, Taniki N, et al
   Dynamics of type IV collagen 7S fragment on eradication of HCV with direct antiviral agents: Prognostic and metabolomic impacts.
   PLoS One. 2022;17:e0276925.
   PubMed         Abstract available
   
   
6. CHIA CT, Bender AT, Lillis L, Sullivan BP, et al
   Rapid detection of hepatitis C virus using recombinase polymerase amplification.
   PLoS One. 2022;17:e0276582.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: